Actualités s/1117

Images about s/1117

Seismic Therapeutic Presents New Preclinical Data on S-1117 in Autoantibody-Mediated Diseases Including Myasthenia Gravis at MGFA Scientific Session at AANEM Annual Meeting

Tue, 15 Oct 2024 01:00:00 GMT

S-1117 is a novel engineered Fc-fused pan-IgG protease targeting IgG autoantibodies that play a key role in the pathogenesis of a range of chronic and acute autoantibody mediated diseases ...


Pan-IgG protease S-1117 offers unique multi-mechanistic approach

Tue, 15 Oct 2024 16:59:00 GMT

Myasthenia gravis (MG) is an antibody-mediated chronic neuromuscular disorder leading to fluctuating weakness and early muscle fatigue, with limited treatment options available. In MG, such as other ...